Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 106

1.

Deacetylated microbial biofilm exopolysaccharides: It pays to be positive.

Ostapska H, Howell PL, Sheppard DC.

PLoS Pathog. 2018 Dec 27;14(12):e1007411. doi: 10.1371/journal.ppat.1007411. eCollection 2018 Dec. No abstract available.

2.

PgaB orthologues contain a glycoside hydrolase domain that cleaves deacetylated poly-β(1,6)-N-acetylglucosamine and can disrupt bacterial biofilms.

Little DJ, Pfoh R, Le Mauff F, Bamford NC, Notte C, Baker P, Guragain M, Robinson H, Pier GB, Nitz M, Deora R, Sheppard DC, Howell PL.

PLoS Pathog. 2018 Apr 23;14(4):e1006998. doi: 10.1371/journal.ppat.1006998. eCollection 2018 Apr.

3.

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.

Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, Lass-Flörl C, Lewis RE, Munoz P, Verweij PE, Warris A, Ader F, Akova M, Arendrup MC, Barnes RA, Beigelman-Aubry C, Blot S, Bouza E, Brüggemann RJM, Buchheidt D, Cadranel J, Castagnola E, Chakrabarti A, Cuenca-Estrella M, Dimopoulos G, Fortun J, Gangneux JP, Garbino J, Heinz WJ, Herbrecht R, Heussel CP, Kibbler CC, Klimko N, Kullberg BJ, Lange C, Lehrnbecher T, Löffler J, Lortholary O, Maertens J, Marchetti O, Meis JF, Pagano L, Ribaud P, Richardson M, Roilides E, Ruhnke M, Sanguinetti M, Sheppard DC, Sinkó J, Skiada A, Vehreschild MJGT, Viscoli C, Cornely OA.

Clin Microbiol Infect. 2018 May;24 Suppl 1:e1-e38. doi: 10.1016/j.cmi.2018.01.002. Epub 2018 Mar 12.

PMID:
29544767
4.

Hoisted by their own petard: do microbial enzymes hold the solution to treating and preventing biofilm infections?

Snarr BD, Howell PL, Sheppard DC.

Future Microbiol. 2018 Mar;13:395-398. doi: 10.2217/fmb-2017-0243. Epub 2018 Feb 14. No abstract available.

PMID:
29441819
5.

Contribution of IL-1RI Signaling to Protection against Cryptococcus neoformans 52D in a Mouse Model of Infection.

Shourian M, Ralph B, Angers I, Sheppard DC, Qureshi ST.

Front Immunol. 2018 Jan 19;8:1987. doi: 10.3389/fimmu.2017.01987. eCollection 2017.

6.

The Interface between Fungal Biofilms and Innate Immunity.

Kernien JF, Snarr BD, Sheppard DC, Nett JE.

Front Immunol. 2018 Jan 10;8:1968. doi: 10.3389/fimmu.2017.01968. eCollection 2017. Review.

7.

Immune Recognition of Fungal Polysaccharides.

Snarr BD, Qureshi ST, Sheppard DC.

J Fungi (Basel). 2017 Aug 28;3(3). pii: E47. doi: 10.3390/jof3030047. Review.

8.

PtaB, a lim-domain binding protein in Aspergillus fumigatus regulates biofilm formation and conidiation through distinct pathways.

Zhang S, Chen Y, Ma Z, Chen Q, Ostapska H, Gravelat FN, Lu L, Sheppard DC.

Cell Microbiol. 2018 Jan;20(1). doi: 10.1111/cmi.12799. Epub 2017 Nov 17. Erratum in: Cell Microbiol. 2018 Mar;20(3):.

PMID:
29114981
9.

Cross-Reacting Ustilago maydis Causing False-Positive Cryptococcal Antigen Test Results.

Cheng MP, Nguyen TT, Parkes LO, Dufresne PJ, Sheppard DC.

J Clin Microbiol. 2017 Oct;55(10):3135-3137. doi: 10.1128/JCM.00920-17. Epub 2017 Jul 26. No abstract available.

10.

FungiScope -Global Emerging Fungal Infection Registry.

Seidel D, Durán Graeff LA, Vehreschild MJGT, Wisplinghoff H, Ziegler M, Vehreschild JJ, Liss B, Hamprecht A, Köhler P, Racil Z, Klimko N, Sheppard DC, Herbrecht R, Chowdhary A, Cornely OA, FungiScope Group.

Mycoses. 2017 Aug;60(8):508-516. doi: 10.1111/myc.12631.

PMID:
28730644
11.

Microbial glycoside hydrolases as antibiofilm agents with cross-kingdom activity.

Snarr BD, Baker P, Bamford NC, Sato Y, Liu H, Lehoux M, Gravelat FN, Ostapska H, Baistrocchi SR, Cerone RP, Filler EE, Parsek MR, Filler SG, Howell PL, Sheppard DC.

Proc Natl Acad Sci U S A. 2017 Jul 3;114(27):7124-7129. doi: 10.1073/pnas.1702798114. Epub 2017 Jun 20.

12.

Serious fungal infections in Canada.

Dufresne SF, Cole DC, Denning DW, Sheppard DC.

Eur J Clin Microbiol Infect Dis. 2017 Jun;36(6):987-992. doi: 10.1007/s10096-017-2922-y. Epub 2017 Feb 4.

PMID:
28161745
13.

7th Advances Against Aspergillosis: Basic, diagnostic, clinical and therapeutic studies.

Cramer RA, Sheppard DC, Clemons KV.

Med Mycol. 2017 Jan 1;55(1):1-3. No abstract available.

PMID:
27994098
14.

Aspergillus fumigatus CalA binds to integrin α5β1 and mediates host cell invasion.

Liu H, Lee MJ, Solis NV, Phan QT, Swidergall M, Ralph B, Ibrahim AS, Sheppard DC, Filler SG.

Nat Microbiol. 2016 Nov 14;2:16211. doi: 10.1038/nmicrobiol.2016.211.

15.

Aspergillus in chronic lung disease: Modeling what goes on in the airways.

Takazono T, Sheppard DC.

Med Mycol. 2017 Jan 1;55(1):39-47. Epub 2016 Nov 12. Review.

PMID:
27838644
16.

Posaconazole-Loaded Leukocytes as a Novel Treatment Strategy Targeting Invasive Pulmonary Aspergillosis.

Baistrocchi SR, Lee MJ, Lehoux M, Ralph B, Snarr BD, Robitaille R, Sheppard DC.

J Infect Dis. 2017 Jun 1;215(11):1734-1741. doi: 10.1093/infdis/jiw513.

17.

Aspergillosis and stem cell transplantation: An overview of experimental pathogenesis studies.

Al-Bader N, Sheppard DC.

Virulence. 2016 Nov 16;7(8):950-966. Epub 2016 Sep 29. Review.

18.

Exopolysaccharide biosynthetic glycoside hydrolases can be utilized to disrupt and prevent Pseudomonas aeruginosa biofilms.

Baker P, Hill PJ, Snarr BD, Alnabelseya N, Pestrak MJ, Lee MJ, Jennings LK, Tam J, Melnyk RA, Parsek MR, Sheppard DC, Wozniak DJ, Howell PL.

Sci Adv. 2016 May 20;2(5):e1501632. doi: 10.1126/sciadv.1501632. eCollection 2016 May.

19.

Microbial Biofilms in Pulmonary and Critical Care Diseases.

Boisvert AA, Cheng MP, Sheppard DC, Nguyen D.

Ann Am Thorac Soc. 2016 Sep;13(9):1615-23. doi: 10.1513/AnnalsATS.201603-194FR. Review.

20.

Decreased Cell Wall Galactosaminogalactan in Aspergillus nidulans Mediates Dysregulated Inflammation in the Chronic Granulomatous Disease Host.

Henriet SS, van de Sande WW, Lee MJ, Simonetti E, Momany M, Verweij PE, Rijs AJ, Ferwerda G, Sheppard DC, de Jonge MI, Warris A.

J Interferon Cytokine Res. 2016 Aug;36(8):488-98. doi: 10.1089/jir.2015.0095. Epub 2016 May 4.

PMID:
27142572

Supplemental Content

Loading ...
Support Center